The potential impact of the COVID-19 pandemic on antimicrobial resistance and antibiotic stewardship

Virusdisease. 2021 Jun;32(2):330-337. doi: 10.1007/s13337-021-00695-2. Epub 2021 May 25.

Abstract

The rapid emergence and spread of antimicrobial resistance continue to kill an estimated 700,000 people annually, and this number is projected to increase ten-fold by 2050. With the lack of data, it is uncertain how the COVID-19 pandemic will affect antimicrobial resistance. Severe disruption of research, innovation, global health programs, and compromised antimicrobial stewardship, infection prevention and control programs, especially in low-and middle-income countries, could affect antimicrobial resistance. However, factors such as strict lockdown, social distancing, vaccination, and the extensive implementation of hand hygiene and face masks, with limited international travel and migration, may also contribute to decreasing AMR. Although the impact of COVID-19 on AMR is global, the adverse effect is likely to be worse in LMICs. In this article, we explore the possible impact of the current pandemic on antibiotic resistance.

Keywords: Antibiotics; Antimicrobial resistance; COVID-19; Coronavirus; LMIC.